Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.145NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.547NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.247NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.4.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.205NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.110NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.434NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.4.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.181NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.6.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.37NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.22NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.21NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-19681.5Japan
BA.5.2.22NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.38NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BF.38.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BF.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BT.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.2.55NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.76NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.30NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BE.11NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.5.2.9NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.31NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-6001.99Japan
BA.4.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.24NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BA.5.6.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.10NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.41NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BS.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BA.5.1.2NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.36NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BM.1.1.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BF.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BF.5.4NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BQ.1.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
BF.5.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-3736.75Japan
BN.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-4248.57Japan
HH.6NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
KN.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
AY.43.1 (Delta)NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.332NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JB.2.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
BA.2.86.7NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.12NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
JW.1.1NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBB.2.3.18NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
XBC.1.6.5NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used